Abstract
Tumor growth and metastasis are angiogenesis-dependent. The possibility of inhibiting tumor growth by interfering with the formation of new vessels has recently raised considerable interest. We previously reported that it is possible to inhibit primary tumor growth and metastasis in a transgenic model of spontaneous breast tumor, which shows many similarities to its human counterpart (including ability to metastasize) by intratumoral administration of a DNA construct carrying the murine angiostatin cDNA driven by liposomes. Here we report that it is also possible to achieve this goal by a systemic (intraperitoneal) delivery of therapeutic DNA constructs carrying genes coding for mouse and human anti-angiogenic factors which include angiostatin, endostatin and TIMP-2. These findings may be relevant to the design of therapeutic interventions in humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hanahan D, Folkman J . Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996 86: 353–364
Hanahan D, Christofori G, Naik P, Arbeit J . Transgenic mouse models of tumor angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models Eur J Cancer 1996 32A: 2386–2393
Fidler IJ, Ellis LM . The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 1994 79: 185–188
O'Reilly MS et al. Angiostatin: a novel angiogenesis inhibitor that mediates the supression of metastases by a Lewis lung carcinoma Cell 1994 79: 315–328
O'Reilly MS, Holmgren L, Chen C, Folkman J . Angiostatin induces and sustains dormancy of human primary tumors in mice Nature Med 1996 2: 689–692
Holmgren L, O'Reilly MS, Folkman J . Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nature Med 1995 1: 149–153
Mauceri HJ et al. Combined effects of angiostatin and ionizing radiation in antitumor therapy Nature 1998 394: 287–291
Boehm T, Folkman J, Browder T, O'Reilly MS . Anti-angiogenic therapy of experimental cancer does not induce drug resistance Nature 1997 390: 404–407
Sacco MG et al. Local regression of breast tumors following intramammary ganciclovir administration in double transgenic mice expressing neu oncogene and herpes simplex virus thymidine kinase Gene Therapy 1995 2: 493–497
Sacco MG et al. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirus-mediated HSV-TK transfer in vivo Gene Therapy 1996 3: 1151–1156
Sacco MG et al. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice Gene Therapy 1998 5: 388–393
Sacco MG et al. Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice Gene Therapy 1999 6: 1893–1897
Sacco MG et al. Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer Cancer Res 2000 60: 2660–2665
Bergers G et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 1999 284: 808–812
Lasic DD . Novel applications of liposomes Trends Biotech 1998 16: 307–321
Matrisian LM . The matrix-degrading metalloproteinases Bioessays 1992 14: 455–463
Nagase H, Woessner JFJ . Matrix metalloproteinases J Biol Chem 1999 274: 21491–21494
Vu TH et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes Cell 1998 93: 411–422
Holmbeck K et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover Cell 1999 99: 81–92
Stetler-Stevenson WG . Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention J Clin Invest 1999 103: 1237–1241
Zhou Z et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I Proc Natl Acad Sci USA 2000 97: 4052–4057
Kleiner DE, Stetler-Stevenson PG . Matrix metalloproteinases and metastasis Cancer Chemother Pharmacol 1999 43: 42–51
Valente P et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis Int J Cancer 1998 75: 246–253
Blezinger P et al. Systematic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene Nat Biotechnol 1999 17: 343–348
Indraccolo S et al. Generation of expression plasmids for angiostatin, endostatin and TIMP-2 for cancer gene therapy Int J Biol Markers 1999 14: 251–256
Acknowledgements
The technical assistance of Massimo Littardi and Lucia Susani is acknowledged. We thank Professor R Dulbecco and Professor L Rossi Bernardi for encouragement. The financial support of AIRC to AV and PF Biotecnologie to PV is gratefully acknowledged. This is manuscript No. 46 of the Genoma 2000/ITBA Project funded by CARIPLO.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sacco, M., Catò, E., Ceruti, R. et al. Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice. Gene Ther 8, 67–70 (2001). https://doi.org/10.1038/sj.gt.3301358
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301358
Keywords
This article is cited by
-
Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment
Journal of Cancer Research and Clinical Oncology (2013)
-
Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression
Breast Cancer Research and Treatment (2009)
-
Gene therapy targeting to tumor endothelium
Cancer Gene Therapy (2007)
-
The promise of genetically engineered mice for cancer prevention studies
Nature Reviews Cancer (2005)
-
Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy
Cancer Gene Therapy (2005)